| Magaca astaanta | ActiTide-BT1 |
| CAS Maya. | 107-88-0; 7732-18-5; 9038-95-3; 61788-85-0; 520-36-5; 508-02-1; 299157-54-3 |
| Magaca INCI | Butylene Glycol; Biyaha; PPG-26-Buteth-26; PEG-40 Saliid Castor Haydaroojiin ah; Apigenin; Oleanolic acid; Biotinoyl Tripeptide-1 |
| Codsiga | Mascara, shaambo |
| Xidhmada | 1kg net halkii dhalo ama 20kgs net halkii durbaan |
| Muuqashada | Dareeraha cad oo dhogor yar leh |
| Waxa ku jira Peptide | 0.015-0.030% |
| Solubility | Biyo milmaya |
| Shaqada | Taxanaha Peptide |
| Nolosha shelf | 1 sano |
| Kaydinta | Ku kaydi meel qabow oo qalalan, oo ka fog iftiinka. 2 ~ 8℃kaydinta. |
| Qiyaasta | 1-5% |
Codsiga
ActiTide-BT1 waxaa lagu dari karaa noocyo kala duwan oo ah qaababka qurxinta. Waxay ka caawisaa inay hoos u dhigto saameynta gabowga iyadoo la yareynayo wax soo saarka dihydrotestosterone (DHT) si loo hagaajiyo atrophy ee timaha follicle, markaa timaha hagaajinta, si looga hortago timo luminta. Isla mar ahaantaana ActiTide-BT1 waxay kor u qaadaysaa kororka unugyada iyo kala soocida taasoo keentay kororka timaha, kor u kaca xoogga timaha iyo mugga. Hawshani waxay sidoo kale khusaysaa jeedal indhaha, waxay u muuqdaan kuwo dheer, buuxa oo xoog badan. ActiTide-BT1 waxay ku fiican tahay in loo isticmaalo alaabta daryeelka timaha oo ay ku jiraan shaambooyinka, qaboojiyaha, maaskaro, serum iyo daawaynta madaxa. ActiTide-BT1 sidoo kale waxay ku fiican tahay isticmaalka mascara iyo alaabta daryeelka indhaha. Astaamaha ActiTide-BT1 waa sida soo socota:
1) Waxay ka dhigtaa indho-shareeraha inay u muuqdaan kuwo dheer, buuxa oo xoog badan.
2) Waxay kor u qaadaa badinta guluubka timaha keratinocyte waxayna hubisaa in timaha xidhitaanka ugu fiican ay kicinayso isku-dhafka iyo abaabulka molecules adhesion Laminin 5 iyo Collagen IV.
3) Waxay kor u qaadaa koritaanka timaha, waxay joojisaa daadinta timaha waxayna xoojisaa timaha.
4)Waxay kicisaa timaha follicles si ay u soo saaraan timo caafimaad qaba,waxa ay caawisaa wareegga dhiigga madaxa iyo in ay firfircooni geliso xuubabka timaha.
